BFRG — BullFrog AI Holdings, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1829247 ·
Last close
$0.41
Market Cap
$7.59M
52W High
$1.96
52W Low
$0.39
ADV30
1,084,242
Next earnings
—
Bullfrog AI Holdings, Inc. operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole, which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; and BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 63,578 10,036 -2,051,769 -2,011,881 5,794,554 4,989,914 719,310
Jun 2026 215,385 106,899 -1,419,061 -1,371,530 7,693,852 6,918,141 706,590
Mar 2026 0 0 -1,614,627 -1,593,161 5,538,863 5,080,463 652,072
Dec 2025 0 0 -1,498,660 -1,480,174 2,808,351 2,183,705 672,022

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-5,499,495
Investing CF
$0
Financing CF
$9,944,001
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.49
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-26,256,315
Inventory
—
Receivables
$215,385
ST Investments
—
EBIT TTM
$-5,990,957
Pretax Income TTM
$-5,996,477
Interest Exp TTM
$5,520
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$298,798
EBITDA
$-6,100,306
Free Cash Flow
$-3,324,448
Enterprise Value
$3,212,302
Total Cash
$6,918,141
Total Debt
$90,138
Shares Out
18,541,651
Trailing EPS
$-0.46
Book Value
$0.38
ROE
-130.7%
ROA
-72.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 116,670 -6,594,636 -6,498,068 2,808,351 672,022 2,136,329 -5,522,265
Dec 2024 0 -7,236,383 -6,993,647 5,551,830 588,090 4,963,740 -5,610,249
Dec 2023 65,000 -5,367,524 -5,355,869 2,776,586 184,350 2,592,236 -6,001,299
Dec 2022 10,000 -2,455,801 -2,802,487 80,369 3,137,721 -3,057,352 -910,890

TTM Snapshot

Revenues TTM
$315,187
NetIncome TTM
$-5,996,477
OpCashFlow TTM
—
Assets (Latest)
$7,693,852
Forward EPS
$-0.17

Peers — same industry

TickerNameMarket CapLastDaily %
ENSC Ensysce Biosciences, Inc. $7.47M $0.38 —
UPC Universe Pharmaceuticals INC $7.81M $1.56 —
CURX Curanex Pharmaceuticals Inc $7.37M $4.70 —
RKTO Rocket One Inc. $7.89M $0.32 —
XCUR EXICURE, INC. $7.07M $1.08 —

News headlines (Yahoo Finance, 1h cache)

Bullfrog AI Holdings Inc. (BFRG) Reports Q3 Loss, Lags Revenue Estimates
2026-11-13 21:25 · Yahoo
BullFrog AI to Present at the 20th Annual LD Micro Main Event on October 20, 2026
2026-10-13 12:00 · Yahoo
BullFrog AI Advances Major Depressive Disorder Drug Discovery Program With Global Pharma Partner
2026-10-06 14:39 · Yahoo
Is Bullfrog AI Holdings Inc. (BFRG) Outperforming Other Medical Stocks This Year?
2026-09-24 12:40 · Yahoo
BullFrog AI to Participate in September 2026 Investor Conferences
2026-09-08 20:15 · Yahoo
BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference
2026-07-22 20:15 · Yahoo
BullFrog AI Announces Participation at AACR Annual Meeting
2026-04-14 11:30 · Yahoo
BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
2026-04-22 11:30 · Yahoo
BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
2026-06-02 12:00 · Yahoo
Assembly Biosciences (ASMB) Reports Q3 Loss, Lags Revenue Estimates
2026-11-12 21:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.